Flere firmaers patenter er i farezonen efter omstridt EU-dom: Selskaber, der har fået patent på forskning med visse stamceller, risikerer at komme til at stå med et ugyldigt patent i hånden
A web-based newspaper specialized on Biotech, Medicine & Pharma
Based on my speeches during the stem cell symposium at Carlberg Akademi (21.03.12) I gave an interview and provided input concerning the CJEU's decision in Brüstle. I was cited several times in the article.